A major stakeholder has offloaded a sizable portion of its shares in a leading pharmaceutical company. The transaction involved the sale of a 0.82% stake at an average price of Rs 5,468.99 per share, totalling a substantial Rs 541.16 crore. This bulk deal has been accepted by the pharmaceutical company, signalling a shift in its … Continue reading Bulk Deal: Pharma stock in focus after FIIs sell shares worth ₹541 Cr